Siem obtained his PhD in medical pharmacology in 2008 at the University of Leiden, the Netherlands. Entrepreneurial scientist, he contributed to over 20 publications and 5 patents. His career has been in science management in top-end research facilities in Australia, the Netherlands and France. He has conducted research and managed teams in both public research institutes and biotechnology company.
Khaled obtained his PhD in biology in 2010 at the University Pierre and Marie Curie, Paris, France. After a post-doctorate in biology and biochemistry at the Centre of Research in Cell Biology of Montpellier, he completed a master in business administration at the University School of Management of Montpellier (IAE). He was previously marketing innovation analyst at Horiba Medical, a world leader of in vitro diagnostics, where he defined commercial value of new medical innovations, and liaised with KOLs to understand unmet needs in clinical care.
Guillaume is a seasoned protein biochemist trained to microtubule biochemistry in the ‘Tubulin code’ team at the Institute of Human Genetics (IGH) in Montpellier. He masters microtubule (MT) related biochemistry and further developed skills in bio-informatics applied to drug design. Guillaume has over 10 years applied biochemistry expertise and worked in governmental research organizations, SMEs and large companies.
Yoann is a skilled molecular and cellular biologist trained in academic, hospital and industry settings where he conducted R&D programs and medical analysis for over 10 years. He is trained as microtubule biologist at the Institute of Human Genetics (IGH) in Montpellier and has been key to the initial maturation program. Yoann is knowledgeable in laboratory automation and in implementation of screening methodologies.
Zoé is a freshly graduated chemist from the Ecole Nationale Supérieure de Chimie, Biologie et Physique de Bordeaux (ENSCBP). She has multiple professional experience within the pharmaceutical sector both in France and in The Netherlands.